Back

Triglycerides: a cardiologists’ concern – what are the risks?

28 August 2026 (15:17 - 15:27)
Organised by: Logo
Congress Presentation Part of: ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG) Lipids, Metabolism Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

4 More presentations in this session

Presentation thumbnail
Welcome and agenda
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
ApoC-III targeting: a new era in triglyceride management
Doctor S. Charriere (Bron, FR)
Presentation thumbnail
How I manage my patients with sHTG
Associate Professor T. Stulnig (Vienna, AT)
Presentation thumbnail
Q&A, panel discussion and closing remarks

Access the full session

Session thumbnail
ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG)

The Event

Event poster

ESC Congress 2026

28 August 2026 15:17 CET
You may be interested in
thumbnail
Congress Presentation
Welcome & introduction
29 August 2025
thumbnail
ESC TV Today
Episode 9: Atrial fibrillation in athletes - Work and life of a medical journalist
13 February 2025
thumbnail
Congress Presentation
Association between triglyceride with all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong
20 May 2023
thumbnail
Congress Presentation
Baseline triglycerides and non-HDL-C and apoB goal attainment in the ORION-10 and ORION-11 trials
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources